Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

The skin's immune system helps it regenerate and fight infections.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Ancient immune and signaling pathways still regulate blood cell development.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Hair follicles regulate immune cells in the skin, and disrupting certain pathways can lead to skin issues and infections.

Innate immunity genes in hair follicle stem cells might have new roles beyond traditional immune functions.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Nanotechnology can improve tissue healing by controlling immune responses.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Blocking LFA-1 prevents hair loss in mice.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Somatostatin may help protect hair follicles from immune attacks.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.